Arkema's Stock Drops 2.39% and Breaks Below Its Support Threshold

Significant Drop in Tuesday's Session

The session on October 14 ended with a 2.39% drop, bringing the price to €49.44, down from €50.65 the previous day. This decline is part of a marked downward trend, with a cumulative loss of 6.89% over the past week and 22.39% over the past three months. The traded volumes accounted for 0.29% of the capital, a moderate level but sufficient to indicate some selling pressure. Over the year, the stock has fallen by 42.04%, in stark contrast to the CAC 40, which has gained 4.51% over the same period, highlighting the extent of the sector-specific and company-specific downturn. The closing price has now fallen below the technical support threshold identified at €49.74, marking a new area of vulnerability. This movement occurs as the stock is trading well below its 50-day (€58.04) and 200-day (€66.51) moving averages, reflecting a firmly established downward trend both short and medium-term. The gap between the current price and these historical benchmarks measures the magnitude of the ongoing correction and the distance from previous levels.

Continued Deterioration Following Analysts' Downward Revisions

This new deterioration follows a series of downward revisions of price targets by several analysts. On October 8, JP Morgan lowered its target from €65 to €55, while maintaining a neutral recommendation on the stock. A few days later, on October 13, Bernstein also reduced its target, from €56 to €50. These adjustments come in the wake of the company's downward revision of its annual financial targets announced at the end of July, which then anticipated an EBITDA between €1.3 and €1.4 billion, down from €1.532 billion in 2024, and a current cash flow reduced to a range of €300 to €400 million, far from the initially hoped €600 million. The operational context remains marked by persistent weakness in demand in Europe and the United States, as well as by macroeconomic and geopolitical uncertainties. The results of the second quarter had already illustrated this difficult situation, with revenues down by 5.6% and net profit plummeting by 67.6% over the period. These elements have fueled investor caution and weighed on the stock's valuation in recent weeks.

Technical Indicators Confirm Current Downward Pressure

On the technical front, several indicators confirm the current downward pressure. The Relative Strength Index (RSI) is at 25, a level that indicates a pronounced oversold zone and suggests that the stock has been heavily abandoned in the short term. Although this setup can sometimes precede a technical rebound, it does not provide a clear buy signal in the absence of a positive catalyst. The MACD, a momentum indicator, shows a line at -2.12, below its signal line (-1.85), with a negative histogram at -0.27, confirming the persistence of a bearish dynamic with no signs of an imminent turnaround. The Bollinger Bands currently frame fluctuations between €49.51 (lower bound) and €59.01 (upper bound), with the price now touching the lower limit. This position illustrates the recent contraction in volatility and the concentration of trades in a tightened price zone. The Chaikin Money Flow (CMF), at -0.27, points towards a clear outflow of capital, reinforcing the idea of dominant selling pressure. With a beta of 0.04, the stock shows almost no sensitivity to movements in the CAC 40, which fell by 0.18% during the session, a configuration that reflects more company-specific factors than broader market dynamics.